SCHEMBL1116166

SCHEMBL1116166

Cc1noc(C)c1-c1ccc(C=C2N=C(N)NC2=O)o1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA2 P00918 2/20 0.38
▸ DYRK3 O43781 1/20 0.38
▸ PIM1 P11309 1/20 0.38
▸ CSNK2A2 P19784 1/20 0.38
▸ CSNK2B P67870 1/20 0.38
▸ CSNK2A1 P68400 1/20 0.38
▸ DYRK1A Q13627 1/20 0.38
▸ CSNK2A3 Q8NEV1 1/20 0.38
▸ DYRK2 Q92630 1/20 0.38
▸ DYRK1B Q9Y463 1/20 0.38
▸ HTR2A P28223 4/20 0.37
▸ CA1 P00915 1/20 0.37
▸ CLK1 P49759 1/20 0.37
▸ CLK2 P49760 1/20 0.37
▸ CLK4 Q9HAZ1 1/20 0.37
▸ BRD4 O60885 6/20 0.34
▸ GSK3A P49840 1/20 0.33
▸ GSK3B P49841 1/20 0.33
▸ DUSP3 P51452 1/20 0.33
▸ NEK6 Q9HC98 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1116165 1.00 CA2 (0.38) CA2DYRK3PIM1CSNK2A2CSNK2B
SCHEMBL1115917 0.78 CLK1 (0.41) DYRK3DYRK1ADYRK2DYRK1BCLK1
SCHEMBL1115919 0.78 CLK1 (0.41) DYRK3DYRK1ADYRK2DYRK1BCLK1
SCHEMBL1116168 0.74 CA2 (0.42) CA2DYRK3PIM1CSNK2A2CSNK2B
SCHEMBL1116262 0.73 HTR2A (0.54) CA2HTR2ACA1CLK1CLK2
SCHEMBL1116264 0.73 HTR2A (0.54) CA2HTR2ACA1CLK1CLK2
SCHEMBL1116271 0.72 BRD4 (0.53) BRD4BRD2KDM4EALDH1A1POLB
SCHEMBL12899354 0.71 HTR2A (0.50) CA2DYRK3PIM1CSNK2A2CSNK2B
SCHEMBL6859308 0.70 IDH1 (0.41) BRD4GSK3AGSK3BBRD2KDM4E
SCHEMBL1228305 0.70 BRAF (0.60) GSK3AGSK3BDUSP3ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011015646-A2 FURAN-IMIDAZOLONE DERIVATIVES, FOR THE TREATMENT OF COGNITIVE, NEURODEGENERATIVE OR NEURONAL DISEASES OR DISORDERS NOSCIRA, S.A. (ES) 2011-02-10 — — WO disclosed
EP-2281824-A1 Furan-imidazolone derivatives, for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders NOSCIRA, S.A. (ES) 2011-02-09 — — EP disclosed
Send feedback